Sumitomo Pharma Co Ltd
TSE:4506

Watchlist Manager
Sumitomo Pharma Co Ltd Logo
Sumitomo Pharma Co Ltd
TSE:4506
Watchlist
Price: 591 JPY -6.49% Market Closed
Market Cap: 234.8B JPY
Have any thoughts about
Sumitomo Pharma Co Ltd?
Write Note

Sumitomo Pharma Co Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sumitomo Pharma Co Ltd
Net Income (Common) Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Sumitomo Pharma Co Ltd
TSE:4506
Net Income (Common)
-ÂĄ260.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Net Income (Common)
ÂĄ149.9B
CAGR 3-Years
-30%
CAGR 5-Years
19%
CAGR 10-Years
4%
Daiichi Sankyo Co Ltd
TSE:4568
Net Income (Common)
ÂĄ229.1B
CAGR 3-Years
42%
CAGR 5-Years
15%
CAGR 10-Years
13%
Otsuka Holdings Co Ltd
TSE:4578
Net Income (Common)
ÂĄ126.8B
CAGR 3-Years
-6%
CAGR 5-Years
8%
CAGR 10-Years
-2%
Chugai Pharmaceutical Co Ltd
TSE:4519
Net Income (Common)
ÂĄ387B
CAGR 3-Years
15%
CAGR 5-Years
23%
CAGR 10-Years
22%
Astellas Pharma Inc
TSE:4503
Net Income (Common)
ÂĄ54.6B
CAGR 3-Years
-18%
CAGR 5-Years
-25%
CAGR 10-Years
-6%

See Also

What is Sumitomo Pharma Co Ltd's Net Income (Common)?
Net Income (Common)
-260.2B JPY

Based on the financial report for Jun 30, 2024, Sumitomo Pharma Co Ltd's Net Income (Common) amounts to -260.2B JPY.

What is Sumitomo Pharma Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 1Y
-80%

Over the last year, the Net Income (Common) growth was -80%.

Back to Top